Us2.ai automatically generates clinically relevant and reproducible quantitative echocardiographic left ventricular (LV) measurements, eliminating human intra-operator variability and reducing analysis time, as reported in Nature Communications.
A study presented at ACC.24 aimed to assess the effectiveness of Us2.ai when utilizing ultrasound enhancing agents. The results indicated a strong agreement between human interpretations and AI, validating the potential of AI for contrast echo. This expands the range of AI capabilities and benefits within clinical workflows.
